Immunomodulation |
Lactobacillus |
Induce TNF-α secretion by lipoteichoic acid (LTA) [5] |
Bifidobacterium longum |
Modulate TNF-α, IL-6, IL-10 and IL-12 and TH17 responses [6] due to its surface exopolysaccharide |
B. animalislactis Bb-12 |
Activated intestinal NF-κB [7] |
IgA secretion [8] |
Improving the immune system and cytokine production in COVID-19 patients |
Lactobacillus |
As adjuvant nutritional therapies in COVID-19 patients [9–11] |
Protective effects against physiological stress |
L. acidophilus (strain LAP5 and LF33) |
Bind to the intestinal epithelial cells and blocked the colonization of Salmonella [12] |
L. acidophilus A4 |
Antagonize adhesion of the E. coli adhesion to epithelial cells by up-regulation of mucin-2, IL-8, IL-1β and TNF-α [13] |
Bifidobacterium spp. |
Produce acetate and inhibit Shiga toxin–producing E. coli O157:H7 [14] |
Lactobacilus and Enterococcus
|
Produce bacteriocins [15, 16] |
L. salivarius UCC118 |
Protect infected mice with L. monocytogenes [17] |
L. acidophilus La-5 1 |
Inhibited autoinducer-2 (AI-2) and decreased the virulence factors expression of E. coli O157:H7 [18] |
L. acidophilus GP1B |
Prevented AI-2 activity of Clostridioides difficile [19] |
L. reuteri RC-14 |
Production of mediators against Staphylococcus aureus QS, blocked its virulence, and expression of toxic shock syndrome toxin-1 [20] |
Suppression of pathogens |
L. plantarum |
Reduce hydroxy-cis-12-octadecenoic acid via regulation of TNF receptor 2 expression and MEK/ERK pathway [21] |
Modulation of gut microbiome and Intestinal Barrier Function |
L. fermentum and L. plantarum
|
In context to Obesity [22, 23], Produce Short Chain Fatty Acids (SCFAs) and Acetic acid, improve tight junction proteins, regulating the immune response, and stimulating host defense peptides [24] |
Other mechanisms |
Lactobacillus and Bifidobacterium
|
Reduction weight gain, decrease the levels of plasma cholesterol and liver triglycerides [25, 26], bile acids deconjugation [27], impaired glucose tolerance [28] |
L. rhamnosus JB-1 |
Modified the γ-aminobutyric acid (GABA)-A expression and GABA-B receptors in the brain related to stress and anxiety-related responses [29] |
L. reuteri ATCC PTA 6475 |
Showed an anti-nociceptive effect via transient receptor potential vanilloid 1 -dependent manner [30] |
L. acidophilus NCFM |
Induced expression of μ-opioid and cannabinoid receptors in the gut epithelial cells and presented analgesic impact [31] |